Manas AI

Manas AI is a technology company using advanced AI and computational chemistry to accelerate drug discovery for cancer and rare diseases.

Manas AI is a drug discovery company that uses artificial intelligence and computational chemistry to accelerate the development of new medicines. The company combines proprietary AI models, advanced molecular docking techniques, and biological expertise to identify promising drug candidates for cancer and rare diseases. Manas AI’s platform generates custom chemical libraries and employs AI filters to rapidly select high-potential therapeutic compounds. Through a partnership with Microsoft, the company leverages cloud computing to perform molecular docking at speeds 100 times faster than traditional methods. Manas AI is currently focused on developing treatments for aggressive cancers, with plans to expand into other disease areas in the future.

Schrödinger

Schrödinger is a leading company in the field of drug discovery that is transforming the way therapeutics and materials are discovered.

Schrödinger develops computational software for discovering and designing molecules for drug development and materials science. Its platform combines physics-based molecular simulations, machine learning, and AI to predict molecular properties, screen compounds, optimize drug candidates, and study biological interactions. The company also provides tools for antibody design, protein modeling, materials research, molecular dynamics, and virtual screening.